Loading clinical trials...
Loading clinical trials...
Identifying the Neural Basis of Depression in Parkinson's Disease
Conditions
Interventions
11C-UCB-J
ketamine hydrochloride
Locations
1
United States
Yale University
New Haven, Connecticut, United States
Start Date
September 1, 2024
Primary Completion Date
January 1, 2029
Completion Date
December 1, 2029
Last Updated
March 10, 2026
NCT07330258
NCT06508801
NCT07226661
NCT07115329
NCT07310264
NCT02119611
Lead Sponsor
Yale University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions